Please login to the form below

Not currently logged in
Email:
Password:

Eric Cornut appointed EFPIA interim director general

Steps into the role as Richard Bergström leaves the association

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Eric Cornut as its interim director general, following the resignation of Richard Bergström from the post.

Currently an independent consultant based in Basel, Switzerland, Cornut brings over 25 years of pharmaceutical management experience to the role, including five years as chairman of EFPIA's executive committee.

He most recently served as chief ethics, compliance and policy officer at Novartis, taking up the position in 2014 after a four-year stint as chairman of the board for Novartis Japan.

Having first joined Novartis in 1997 as a general manager in The Netherlands, Cornut has held a number of increasingly senior managerial roles at the Swiss pharma firm, including president of Novartis France, head of Europe and chief commercial officer.

Joe Jiminez, president of EFPIA, said: “Eric brings a wealth of valuable experience, having worked in the pharmaceutical industry for more than 25 years with responsibility for both commercial and policy work.

“I am very pleased that Eric accepted to lead EFPIA ad interim.”

5th January 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

How will capitated budgets affect NHS spending?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the implications of a single budget covering all the physical, mental and social care needs of patients in an STP...
Dissecting adherence to personalise patient support
Across the healthcare and pharmaceutical industries, the initiatives to better understand the patient journey and lower healthcare costs have been growing in magnitude. One solution that has repeatedly been raised...
A safe place to talk about Crohn’s
Published in eyeforpharma April 2017 by Mariel Metcalfe...

Infographics